Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor
Open accessAbstract
The EphA4 receptor tyrosine kinase interacts with ephrin ligands to regulate many processes, ranging from axon guidance and nerve regeneration to cancer malignancy. Thus antagonists that inhibit ephrin binding to EphA4 could be useful for a variety of research and therapeutic applications. In the present study we characterize the binding features of three antagonistic peptides (KYL, APY and VTM) that selectively target EphA4 among the Eph receptors. Isothermal titration calorimetry analysis demonstrated that all three peptides bind to the ephrin-binding domain of EphA4 with low micromolar affinity. Furthermore, the effects of a series of EphA4 mutations suggest that the peptides interact in different ways with the ephrin-binding pocket of EphA4. Chemical-shift changes observed by NMR spectroscopy upon binding of the KYL peptide involve many EphA4 residues, consistent with extensive interactions and possibly receptor conformational changes. Additionally, systematic replacement of each of the 12 amino acids of KYL and VTM identify the residues critical for EphA4, binding. The peptides exhibit a long half-life in cell culture medium which, with their substantial binding affinity and selectivity for EphA4, makes them excellent research tools to modulate EphA4 function.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The inhibitory EphA4 peptide KYL protects neurons from synaptotoxicity with exposure to oAβ.
“The inhibitory EphA4 peptide, KYL was found to protect neurons from the synaptotoxicity with exposure to oAβ [82].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Eph-Ephrin Bidirectional Signaling in Physiology and Disease
Pasquale, E. B. (2008) · Cell · doi:10.1016/j.cell.2008.03.011 · Cited by 1,251 · see citing works
Self-citationEph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2806 · Cited by 1,216 · see citing works
Self-citationEph receptor signalling casts a wide net on cell behaviour
Pasquale, E. B. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1662 · Cited by 1,013 · see citing works
Self-citationRole of EphA4 and EphrinB3 in Local Neuronal Circuits That Control Walking
Kullander, K., Butt, S., Lebret, J. M., Lundfald, L., Restrepo, C. E., Rydström, A., Klein, R., & Kiehn, O. (2003) · Science · doi:10.1126/science.1079641 · Cited by 365 · see citing works
Crystal structure of an Eph receptor–ephrin complex
Himanen, J., Rajashankar, K. R., Lackmann, M., Cowan, C. A., Henkemeyer, M. J., & Nikolov, D. B. (2001) · Nature · doi:10.1038/414933a · Cited by 339 · see citing works
On the Convergent Evolution of Animal Toxins
Dauplais, M., Lecoq, A., Song, J., Cotton, J., Jamin, N., Gilquin, B., Roumestand, C., Vita, C., de Medeiros, C. L. C., Rowan, E. G., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4302 · Cited by 337 · see citing works
Self-citationAxonal Regeneration and Lack of Astrocytic Gliosis in EphA4-Deficient Mice
Goldshmit, Y., Galea, M. P., Wise, G. E., Bartlett, P. F., & Turnley, A. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2981-04.2004 · Cited by 318 · see citing works
Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism
Fu, W., Chen, Y., Şahin, M., Zhao, X.-S., Shi, L., Bikoff, J. B., Lai, K., Yung, W., Fu, A. K. Y., Greenberg, M. E., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1811 · Cited by 311 · see citing works
Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport
Filosa, A., Paixão, S., Honsek, S. D., Carmona, M. A., Becker, L., Feddersen, B., Gaitanos, L., Rudhard, Y., Schoepfer, R., Klopstock, T., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2394 · Cited by 283 · see citing works
Self-citationArchitecture of Eph receptor clusters
Himanen, J. P., Yermekbayeva, L., Janes, P. W., Walker, J. R., Xu, K. Y., Atapattu, L., Rajashankar, K. R., Mensinga, A., Lackmann, M., Nikolov, D. B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004148107 · Cited by 259 · see citing works
Kullander, K., Mather, N. K., Diella, F., Dottori, M., Boyd, A., & Klein, R. (2001) · Neuron · doi:10.1016/s0896-6273(01)00181-7 · Cited by 258 · see citing works
Hippocampal plasticity requires postsynaptic ephrinBs
Kadow, I. C. G., Körte, M., Adelmann, G., Plück, A., Kullander, K., Adams, R. H., Frotscher, M., Bonhoeffer, T., & Klein, R. (2003) · Nature Neuroscience · doi:10.1038/nn1164 · Cited by 252 · see citing works
Ashida, S., Nakagawa, H., Katagiri, T., Furihata, M., Iiizumi, M., Anazawa, Y., Tsunoda, T., Takata, R., Kasahara, K., Miki, T., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0020 · Cited by 239 · see citing works
An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly
Seiradake, E., Harlos, K., Sutton, G. C., Aricescu, A. R., & Jones, E. Y. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1782 · Cited by 222 · see citing works
An Ephrin Mimetic Peptide That Selectively Targets the EphA2 Receptor
Koolpe, M., Dail, M., & Pasquale, E. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208495200 · Cited by 211 · see citing works
Self-citationGlial ephrin-A3 regulates hippocampal dendritic spine morphology and glutamate transport
Carmona, M. A., Murai, K. K., Wang, L., Roberts, A. J., & Pasquale, E. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903328106 · Cited by 208 · see citing works
Self-citationScarberry, K. E., Dickerson, E. B., McDonald, J. F., & Zhang, Z. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801969b · Cited by 201 · see citing works
Cooperation between GDNF/Ret and ephrinA/EphA4 Signals for Motor-Axon Pathway Selection in the Limb
Kramer, E. R., Knott, L., Su, F., Dessaud, É., Krull, C. E., Helmbacher, F., & Klein, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.02.020 · Cited by 195 · see citing works
Eph–ephrin promiscuity is now crystal clear
Pasquale, E. B. (2004) · Nature Neuroscience · doi:10.1038/nn0504-417 · Cited by 167 · see citing works
Self-citationvan Doorn, R., Dijkman, R., Vermeer, M. H., Out‐Luiting, J. J., van der Raaij-Helmer, E. M. H., Willemze, R., & Tensen, C. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1253 · Cited by 163 · see citing works
Connor, R., Menzel, P., & Pasquale, E. B. (1998) · Developmental Biology · doi:10.1006/dbio.1997.8786 · Cited by 151 · see citing works
Self-citationThe EphA4 receptor regulates dendritic spine remodeling by affecting β1-integrin signaling pathways
Bourgin, C., Murai, K. K., Richter, M., & Pasquale, E. B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200610139 · Cited by 147 · see citing works
Self-citationFukai, J., Yokote, H., Yamanaka, R., Arao, T., Nishio, K., & Itakura, T. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2263 · Cited by 147 · see citing works
Koolpe, M., Burgess, R., Dail, M., & Pasquale, E. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500363200 · Cited by 143 · see citing works
Self-citationSmall Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors
Noberini, R., Koolpe, M., Peddibhotla, S., Dahl, R. S., Su, Y., Cosford, N. D. P., Roth, G. P., & Pasquale, E. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804103200 · Cited by 135 · see citing works
Self-citationBrantley‐Sieders, D. M., Jiang, A., Sarma, K., Badu-Nkansah, A., Walter, D. L., Shyr, Y., & Chen, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024426 · Cited by 134 · see citing works
Fabes, J., Anderson, P. N., Brennan, C. H., & Bolsover, S. R. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05859.x · Cited by 116 · see citing works
Flanagan, J. G., Cheng, H.-J., Feldheim, D. A., Hattori, M., Lü, Q., & Vanderhaeghen, P. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)27264-9 · Cited by 113 · see citing works
Targeting the EphA4 receptor in the nervous system with biologically active peptides
Murai, K. K., Nguyen, L. N., Koolpe, M., McLennan, R., Krull, C. E., & Pasquale, E. B. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.08.006 · Cited by 106 · see citing works
Self-citationTargeting Eph receptors with peptides and small molecules: Progress and challenges
Noberini, R., Lamberto, I., & Pasquale, E. B. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.10.023 · Cited by 103 · see citing works
Self-citationQin, H., Noberini, R., Huan, X., Shi, J., Pasquale, E. B., & Song, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064824 · Cited by 101 · see citing works
Self-citationRNAi screen for rapid therapeutic target identification in leukemia patients
Tyner, J. W., Deininger, M. W., Loriaux, M., Chang, B. H., Gotlib, J. R., Willis, S. G., Erickson, H. S., Kovacsovics, T. J., O’Hare, T., Heinrich, M. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903233106 · Cited by 99 · see citing works
Chrencik, J., Brooun, A., Kraus, M. L., Recht, M. I., Kolatkar, A. R., Han, G. W., Seifert, J. M., Widmer, H., Auer, M., & Kühn, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605766200 · Cited by 97 · see citing works
Structural Plasticity of Eph Receptor A4 Facilitates Cross-Class Ephrin Signaling
Bowden, T. A., Aricescu, A. R., Nettleship, J. E., Siebold, C., Rahman-Huq, N., Owens, R. J., Stuart, D. I., & Jones, E. Y. (2009) · Structure · doi:10.1016/j.str.2009.07.018 · Cited by 95 · see citing works
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation
Giorgio, C., Mohamed, I. H., Flammini, L., Barocelli, E., Incerti, M., Lodola, A., & Tognolini, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018128 · Cited by 84 · see citing works
Fabes, J., Anderson, P. N., Yáñez‐Muñoz, R. J., Thrasher, A. J., Brennan, C. H., & Bolsover, S. R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04704.x · Cited by 83 · see citing works
Qin, H., Shi, J., Noberini, R., Pasquale, E. B., & Song, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804114200 · Cited by 80 · see citing works
Self-citationZhang, R., Xiong, C., Huang, M. L., Zhou, M., Huang, Q., Wen, X., Liang, D., & Li, C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.070 · Cited by 78 · see citing works
EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactions
Sharfe, N., Nikolic, M., Cimpeon, L., Kratts, A. V. D., Freywald, A., & Roifman, C. M. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.09.019 · Cited by 74 · see citing works
Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers
Oki, M., Yamamoto, H., Taniguchi, H., Adachi, Y., Imai, K., & Shinomura, Y. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5650 · Cited by 72 · see citing works
EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth
Iiizumi, M., Hosokawa, M., Takehara, A., Chung, S., Nakamura, T., Katagiri, T., Eguchi, H., Ohigashi, H., Ishikawa, O., Nakamura, Y., et al. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00313.x · Cited by 71 · see citing works
Protein dynamics and conformational selection in bidirectional signal transduction
Nussinov, R., & Ma, B. (2012) · BMC Biology · doi:10.1186/1741-7007-10-2 · Cited by 65 · see citing works
EphA4 preserves postnatal and adult neural stem cells in an undifferentiated state in vivo
Khodosevich, K. V., Watanabe, Y., & Monyer, H. (2011) · Journal of Cell Science · doi:10.1242/jcs.076059 · Cited by 63 · see citing works
Chrencik, J., Brooun, A., Recht, M. I., Nicola, G., Davis, L. K., Abagyan, R. A., Widmer, H., Pasquale, E. B., & Kühn, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706340200 · Cited by 62 · see citing works
Self-citationGalimberti, I., Bednarek, E., Donato, F., & Caroni, P. (2010) · Neuron · doi:10.1016/j.neuron.2010.02.016 · Cited by 60 · see citing works
Ephrin-A6, a New Ligand for EphA Receptors in the Developing Visual System
Menzel, P., Valencia, F., Godement, P., Dodelet, V. C., & Pasquale, E. B. (2001) · Developmental Biology · doi:10.1006/dbio.2000.0109 · Cited by 59 · see citing works
Self-citationSelective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles
Scarberry, K. E., Dickerson, E. B., Zhang, Z. J., Benigno, B. B., & McDonald, J. F. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.11.003 · Cited by 58 · see citing works
Goldshmit, Y., & Bourne, J. A. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1294 · Cited by 49 · see citing works
In Vivo Small-Animal PET/CT of EphB4 Receptors Using 64Cu-Labeled Peptide
Xiong, C., Huang, M. L., Zhang, R., Song, S., Lü, W., Flores, L. G., Gelovani, J. G., & Li, C. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.081943 · Cited by 45 · see citing works
MINAMI, M., Koyama, T., Wakayama, Y., Fukuhara, S., & Mochizuki, N. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-03-0183 · Cited by 42 · see citing works
A Disalicylic Acid‐Furanyl Derivative Inhibits Ephrin Binding to a Subset of Eph Receptors
Noberini, R., De, S. K., Zhang, Z., Wu, B., Dhanya, R.-P., Chen, V., Vázquez, J., Qin, H., Song, J., Cosford, N. D. P., et al. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01199.x · Cited by 41 · see citing works
Self-citationNoberini, R., Mitra, S., Salvucci, O., Valencia, F., Duggineni, S., Prigozhina, N. L., Wei, K., Tosato, G., Huang, Z., & Pasquale, E. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028611 · Cited by 40 · see citing works
Self-citationSingla, N., Goldgur, Y., Xu, K. Y., Paavilainen, S., Nikolov, D. B., & Himanen, J. P. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.109 · Cited by 30 · see citing works
Scarberry, K. E., Mezencev, R., & McDonald, J. F. (2010) · Nanomedicine · doi:10.2217/nnm.10.103 · Cited by 30 · see citing works
Qin, H., Lim, L., & Song, J. (2012) · BMC Biophysics · doi:10.1186/2046-1682-5-2 · Cited by 23 · see citing works
Self-citationUse of protein array to investigate receptor tyrosine kinases activated in gastric cancer
Masaki, M. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000480 · Cited by 20 · see citing works
[11] Utility of the secreted placental alkaline phosphatase reporter enzyme
Cullen, B. R. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)26053-9 · Cited by 15 · see citing works
Kimura, K., Hikida, T., Yawata, S., Yamaguchi, T., & Nakanishi, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107592108 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works
A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
Lu, H., Clauser, K. R., Tam, W. L., Fröse, J., Ye, X., Eaton, E. N., Reinhardt, F., Donnenberg, V. S., Bhargava, R., Carr, S. A., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3041 · Cited by 457 · see citing works
Eph Receptors and Ephrins: Therapeutic Opportunities
Barquilla, A., & Pasquale, E. B. (2014) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140226 · Cited by 294 · see citing works
Self-citationFu, A. K. Y., Hung, K.-W., Huang, H., Gu, S., Shen, Y., Cheng, E. Y. L., Ip, F. C. F., Huang, X., Fu, W.-Y., & Ip, N. Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405803111 · Cited by 201 · see citing works
Eph receptors and ephrins as targets for cancer therapy
Xi, H., Wu, X., Wei, B., & Chen, L. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01612.x · Cited by 131 · see citing works
EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers
Vargas, L. M., Leal, N. R., Estrada, L. D., González, A., Serrano, F. G., Araya, K. A., Gysling, K., Inestrosa, N. C., Pasquale, E. B., & Alvarez, A. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092309 · Cited by 85 · see citing works
Self-citationRatan, Y., Rajput, A., Maleysm, S., Pareek, A., Jain, V. K., Pareek, A., Kaur, R., & Singh, G. (2023) · Biomedicines · doi:10.3390/biomedicines11051398 · Cited by 87 · see citing works
HTS by NMR of Combinatorial Libraries: A Fragment-Based Approach to Ligand Discovery
Wu, B., Zhang, Z., Noberini, R., Barile, E., Giulianotti, M. A., Pinilla, C., Houghten, R. A., Pasquale, E. B., & Pellecchia, M. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.10.015 · Cited by 80 · see citing works
Self-citationTherapeutic Development in Amyotrophic Lateral Sclerosis
Bucchia, M., Ramirez, A., Parente, V., Simone, C., Nizzardo, M., Magri, F., Dametti, S., & Corti, S. P. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.12.020 · Cited by 77 · see citing works
Vargas, L. M., Cerpa, W. F., Muñoz, F. J., Zanlungo, S., & Alvarez, A. R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.023 · Cited by 69 · see citing works
Wu, B., Barile, E., De, S. K., Wei, J., Purves, A., & Pellecchia, M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150519102459 · Cited by 61 · see citing works
Targeting the Eph System with Peptides and Peptide Conjugates
Riedl, S. J., & Pasquale, E. B. (2015) · Current Drug Targets · doi:10.2174/1389450116666150727115934 · Cited by 54 · see citing works
Self-citationPotent and Selective EphA4 Agonists for the Treatment of ALS
Wu, B., De, S. K., Kulinich, A. O., Salem, A. F., Koeppen, J., Wang, R., Barile, E., Wang, S., Zhang, D., Ethell, I. M., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.01.006 · Cited by 52 · see citing works
EphA4/Tie2 crosstalk regulates leptomeningeal collateral remodeling following ischemic stroke
Okyere, B., Mills, W. A., Wang, X., Chen, M., Jiang, C., Hazy, A., Qian, Y., Matson, J. B., & Theus, M. H. (2019) · Journal of Clinical Investigation · doi:10.1172/jci131493 · Cited by 48 · see citing works
Qin, H., Lim, L., & Song, J. (2014) · ACS Chemical Biology · doi:10.1021/cb500413n · Cited by 48 · see citing works
Self-citationThe Role of Ephs and Ephrins in Memory Formation
Dines, M., & Lamprecht, R. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv106 · Cited by 47 · see citing works
Druggable Orthosteric and Allosteric Hot Spots to Target Protein-protein Interactions
Ma, B., & Nussinov, R. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990073 · Cited by 45 · see citing works
Development and Structural Analysis of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor
Lamberto, I., Lechtenberg, B. C., Olson, E. J., Mace, P. D., Dawson, P. E., Riedl, S. J., & Pasquale, E. B. (2014) · ACS Chemical Biology · doi:10.1021/cb500677x · Cited by 40 · see citing works
Self-citationIdentification and characterization of Nanobodies targeting the EphA4 receptor
Schoonaert, L., Rué, L., Roucourt, B., Timmers, M., Little, S., Chávez‐Gutiérrez, L., Dewilde, M., Joyce, P. I., Curnock, A. P., Weber, P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.774141 · Cited by 39 · see citing works
Tie2 and Eph Receptor Tyrosine Kinase Activation and SignalingPreprint
Barton, W. A., Dalton, A. C., Seegar, T. C. M., Himanen, J. P., & Nikolov, D. B. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009142 · Cited by 35 · see citing works
Lee, H.-H., Wang, Y.-N., Yang, W.-H., Xia, W., Wei, Y.-K., Chan, L.-C., Wang, Y.-H., Jiang, Z., Xu, S., Yao, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23075-2 · Cited by 24 · see citing works
Phan, N. N., Liu, S., Wang, C., Hsu, H., Lai, M., Li, C.-Y., Chen, C., Chiao, C.-C., Yen, M., Sun, Z., et al. (2020) · PubMed Central · Cited by 28 · see citing works
Takano, H., Nakamura, T., Tsuchikawa, T., Kushibiki, T., Hontani, K., Inoko, K., Takahashi, M., Sato, S., Abe, H., Takeuchi, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5729 · Cited by 24 · see citing works
Targeting kinase signaling pathways with constrained peptide scaffolds
Hanold, L. E., Fulton, M. D., & Kennedy, E. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.014 · Cited by 23 · see citing works
Inhibition of Eph receptor–ephrin ligand interaction by tea polyphenols
Noberini, R., Koolpe, M., Lamberto, I., & Pasquale, E. B. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.05.010 · Cited by 20 · see citing works
Self-citationWiniewska‐Szajewska, M., Kucińska, K., Makowska, M., Poznański, J. T., & Shugar, D. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.04.004 · Cited by 19 · see citing works
Defourny, J., Peuckert, C., Kullander, K., & Malgrange, B. (2018) · iScience · doi:10.1016/j.isci.2018.12.017 · Cited by 18 · see citing works
Huan, X., Shi, J., Lim, L., Mitra, S., Zhu, W., Qin, H., Pasquale, E. B., & Song, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074040 · Cited by 16 · see citing works
Self-citationThe roles and therapeutic potentials of Ephs and ephrins in lung cancer
Li, J., & Xie, D. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.08.005 · Cited by 14 · see citing works
Rayatpour, A., & Javan, M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105441 · Cited by 14 · see citing works
Rani, A., Jakhmola, S., Karnati, S., Parmar, H. S., & Jha, H. C. (2021) · Tumour Virus Research · doi:10.1016/j.tvr.2021.200227 · Cited by 14 · see citing works
Dines, M., & Lamprecht, R. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.76 · Cited by 14 · see citing works
Fiore, L., Medori, M., Spelzini, G., Olmos-Carreño, C. L., Carri, N. G., Sánchez, V., & Scicolone, G. E. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.09.007 · Cited by 13 · see citing works
Ganguly, D., Thomas, J. A., Ali, A., & Kumar, R. K. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15591 · Cited by 12 · see citing works
Forse, G. J., Uson, M. L., Nasertorabi, F., Kolatkar, A. R., Lamberto, I., Pasquale, E. B., & Kühn, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127081 · Cited by 12 · see citing works
Self-citationInvestigation of the interactions between the EphB2 receptor and SNEW peptide variants
Ma, B., Kolb, S., Diprima, M., Karna, M., Tosato, G., Yang, Q., Huang, Q., & Nussinov, R. (2014) · Growth Factors · doi:10.3109/08977194.2014.985786 · Cited by 10 · see citing works
NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands
Baggio, C., Kulinich, A. O., Dennys, C. N., Rodrigo, R., Meyer, K., Ethell, I. M., & Pellecchia, M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00608 · Cited by 10 · see citing works
Golan, M., Krivitsky, A., Mausner-Fainberg, K., Benhamou, M., Vigiser, I., Regev, K., Kolb, H., & Karni, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042182 · Cited by 8 · see citing works
Qu, B., Han, Y., Liang, T. B., Zhang, C., Hou, G., & Gao, F. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.104211 · Cited by 5 · see citing works
Gómez‐Soler, M., Olson, E. J., de la Torre, E. R., Zhao, C., Lamberto, I., Flood, D. T., Danho, W., Lechtenberg, B. C., Riedl, S. J., Dawson, P. E., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115876 · Cited by 5 · see citing works
Self-citationNeurodegeneration-associated protein VAPB regulates proliferation in medulloblastoma
Assoni, A. F., Mitsugi, T., Wardenaar, R., Ferreira, R. O., Jandrey, E. H. F., Novaes, G. M., Granha, I. F. D. O., Bakker, P. L., Kaid, C., Zatz, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-45319-5 · Cited by 4 · see citing works
Li, Y., Yamaguchi, H., Liu, Y., Hsu, K.-C., Sun, T.-H., Sun, P.-C., & Hung, M. (2022) · PubMed Central · Cited by 4 · see citing works
Mechanisms of self-assembly and fibrillization of the prion-like domainsPreprint
Lu, Y., Lim, L., Tan, Y., Wang, L., & Song, J. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/065631 · Cited by 3 · see citing works
Self-citationTan, Y., Xia, J., Liu, M., Deng, S., Wu, H., & Qian, C. (2026) · Mediators of Inflammation · doi:10.1155/mi/5595023 · Cited by 2 · see citing works
Eph-mediated restriction of cerebrovascular arteriogenesis
Okyere, B. (2019) · VTechWorks (Virginia Tech) · Cited by 1 · see citing works
Davy, A. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.740114516.793585641
BindingDB Entry 50014039: NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands.
BindingDB (2022) · UC San Diego · doi:10.7270/q2pk0kxt
BindingDB Entry 7902: Potent and Selective EphA4 Agonists for the Treatment of ALS.
BindingDB (2017) · UC San Diego · doi:10.7270/q2gx49fb
- Authors
- Lamberto, I., Qin, H., Noberini, R., Premkumar, L., Bourgin, C., Riedl, S. J., Song, J., & Pasquale, E. B.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- National University of Singapore (SG)
- Corresponding author
- Lamberto, Ilaria
- Noberini, Roberta
- Premkumar, Lakshmanane
- Bourgin, Caroline
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2012-06-15
- Volume
- 445
- Issue
- 1
- Pages
- 47-56
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC3677027
- OpenAlex
- W2110110458
- Cited by
- 48
- References
- 58
- Citations by year
- 2026: 1 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 8 · 2014: 10 · 2013: 2 · 2012: 3
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- National University of Singapore (submittedVersion)
- Funders
- National Cancer Institute (P01CA138390, CA138390)
- National Institute of Neurological Disorders and Stroke (NS067502, R21NS067502)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chemical Synthesis and Analysis
- Keywords
- peptide-receptor binding, receptor tyrosine kinase, binding affinity, binding site residues, receptor conformational change, peptide half-life
- MeSH terms
- Animals, Brain, Calorimetry, Cells, Cultured, Enzyme-Linked Immunosorbent Assay, Humans, Image Processing, Computer-Assisted, Male, Models, Molecular, Mutation, Neuroblastoma, Magnetic Resonance Spectroscopy, Peptide Fragments, Prostatic Neoplasms, Protein Binding, Protein Conformation, Signal Transduction, Mutagenesis, Site-Directed, Receptor, EphA4, Ephrins, Quantum Dots, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review